Perfusion seed cultures improve biopharmaceutical fed‐batch production capacity and product quality
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Volumetric productivity and product quality are two key performance indicators for any biopharmaceutical cell culture process. In this work, we showed proof‐of‐concept for improving both through the use of alternating tangential flow perfusion seed cultures coupled with high‐seed fed‐batch production cultures. First, we optimized the perfusion N‐1 stage, the seed train bioreactor stage immediately prior to the production bioreactor stage, to minimize the consumption of perfusion media for one CHO cell line and then successfully applied the optimized perfusion process to a different CHO cell line. Exponential growth was observed throughout the N‐1 duration, reaching >40 × 10 6 vc/mL at the end of the perfusion N‐1 stage. The cultures were subsequently split into high‐seed (10 × 10 6 vc/mL) fed‐batch production cultures. This strategy significantly shortened the culture duration. The high‐seed fed‐batch production processes for cell lines A and B reached 5 g/L titer in 12 days, while their respective low‐seed processes reached the same titer in 17 days. The shortened production culture duration potentially generates a 30% increase in manufacturing capacity while yielding comparable product quality. When perfusion N‐1 and high‐seed fed‐batch production were applied to cell line C, higher levels of the active protein were obtained, compared to the low‐seed process. This, combined with correspondingly lower levels of the inactive species, can enhance the overall process yield for the active species. Using three different CHO cell lines, we showed that perfusion seed cultures can optimize capacity utilization and improve process efficiency by increasing volumetric productivity while maintaining or improving product quality. © 2014 American Institute of Chemical Engineers Biotechnol. Prog., 30:616–625, 2014
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THEORY OF PROTEIN FOLDING: The Energy Landscape Perspective
Onuchic, J. N., Luthey-Schulten, Z., & Wolynes, P. G. (1997) · Annual Review of Physical Chemistry · doi:10.1146/annurev.physchem.48.1.545 · Cited by 2,210
Kim, J. Y., Kim, Y.-G., & Lee, G. M. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3758-5 · Cited by 801
Cell culture processes for monoclonal antibody production
Li, F., Vijayasankaran, N., Shen, A. (., Kiss, R., & Amanullah, A. (2010) · mAbs · doi:10.4161/mabs.2.5.12720 · Cited by 739
Zhu, M. M., Goyal, A., Rank, D. L., Gupta, S. K., Boom, T. V., & Lee, S. S. (2008) · Biotechnology Progress · doi:10.1021/bp049815s · Cited by 199
CO2 in large-scale and high-density CHO cell perfusion culture
Gray, D. R., Chen, S., Howarth, W., Inlow, D., & Maiorella, B. L. (1996) · Cytotechnology · doi:10.1007/bf00353925 · Cited by 176 · cited 1×
“Methods for reducing pCO2 include a second sparger for open pipe sparging, changing the concentration of or eliminating the use of bicarbonate(26) and modulating the bubble size through new sparger designs.(27,28)”
MethodEnhanced Production of Monomeric Interferon-β by CHO Cells through the Control of Culture Conditions
Rodriguez, J., Spearman, M., Huzel, N., & Butler, M. (2008) · Biotechnology Progress · doi:10.1021/bp049807b · Cited by 145 · cited 1×
“As lower temperatures are more thermodynamically favorable for protein folding,(20) a common protein expression technique for alleviating misfolding is to reduce the culture temperature.(21,22) Thus, the low-seed cell line C process uses a change in temperature from 35 C to 30 C during the culture.”
BackgroundStrategies for Improved dCO 2 Removal in Large‐Scale Fed‐Batch Cultures
Mostafa, S. S., & Gu, X. (. (2003) · Biotechnology Progress · doi:10.1021/bp0256263 · Cited by 113 · cited 1×
“Scale-up will also provide us another opportunity to address CO2 accumulation as higher levels of dissolved CO2 has been observed in large-scale cultures compared to bench-scale cultures.(24,25) Although the shorter duration of our optimized perfusion N-1 process generated lower absolute pCO2 values, the higher N-1 se…”
Result
Cited by
The therapeutic monoclonal antibody market
Ecker, D. M., Jones, S. D., & Levine, H. L. (2015) · mAbs · doi:10.4161/19420862.2015.989042 · Cited by 1,286
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Dumont, J., Euwart, D., Mei, B., Estes, S., & Kshirsagar, R. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1084266 · Cited by 483
Self-citationRitacco, F. V., Wu, Y., & Khetan, A. (2018) · Biotechnology Progress · doi:10.1002/btpr.2706 · Cited by 273
Perfusion mammalian cell culture for recombinant protein manufacturing – A critical review
Bielser, J.-M., Wolf, M., Souquet, J., Broly, H., & Morbidelli, M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.04.011 · Cited by 263
Karst, D. J., Serra, E., Villiger, T. K., Soos, M., & Morbidelli, M. (2016) · Biochemical Engineering Journal · doi:10.1016/j.bej.2016.02.003 · Cited by 151
Metadata
- Authors
- Yang, W. C., Lu, J., Kwiatkowski, C., Yuan, H., Kshirsagar, R., Ryll, T., & Huang, Y.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2014-03-03
- Volume
- 30
- Issue
- 3
- Pages
- 616-625
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W4251342501
- Cited by
- 143
- References
- 7
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.